Aquaculture without antibiotics: Peptobiotics closes Series A round as it seeks to tackle 'acute' overuse and resistance

Singapore start-up Peptobiotics has raised US$6.2M in Series A funding to commercialise its antimicrobial peptide technology as it seeks to replace the use of antibiotics, firstly in aquaculture, and in the future in livestock.

Related Keywords

Australia ,Singapore ,Australian ,Koh Jhee Hong ,Claire Pribula ,Laurent Genet ,Jonathan Bester ,Lab Asia Pacific ,Hatch Blue Revolution Fund ,Trendlines Agrifood Fund ,Blue Revolution Fund ,Seventure Partners ,Yield Lab Asia Pacific ,Jhee Hong ,Board Independent Director ,Managing Director ,Aquaculture ,Antibiotics ,Unctional Additives ,Quaculture ,Seafood ,Ustainability ,